The Online Investor
OLI Premium
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
Pfenex Inc (PFNX)

Pfenex is a development and licensing biotechnology company focused on utilizing its proprietary protein production platform, Pfenex Expression Technology®, to develop protein therapeutics to improve existing therapies and create therapies for diseases still waiting to be addressed. The U.S. Food and Drug Administration-approved PF708 product is indicated for the treatment of osteoporosis in certain patients at high risk for fracture. Co.'s other product includes PF743 (JZP-458), which it is developing in collaboration with Jazz Pharmaceuticals Ireland Limited for the treatment of acute lymphoblastic leukemia. Co. has added PF810, a peptide based therapeutic, to its wholly owned pipeline.

Company Name:  Pfenex Inc
Website:  www.pfenex.com
Sector:  Drugs & Pharmaceuticals
March 29, 2024    10:22 AM Eastern


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes

Email EnvelopeFree PFNX Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Hold (2.40 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)

Analysts' Target Price:
PFNX Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Pfenex Inc (PFNX) Page | The Online Investor | www.TheOnlineInvestor.com | Copyright © 1998 - 2024, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.